Literature DB >> 385455

Duodenal endocrine cells in adult coeliac disease.

K Sjölund, J Alumets, N O Berg, R Håkanson, F Sundler.   

Abstract

Using immunohistochemical techniques we studied duodenal biopsies from 18 patients with coeliac disease and 24 patients with normal duodenal morphology. We had access to antisera against the following gastrointestinal peptides: cholecystokinin (CCK), gastric inhibitory peptide (GIP), gastrin-17, glucagon-enteroglucagon, motilin, neurotensin, pancreatic peptide (PP), secretin, somatostatin, substance P and vasoactive intestinal peptide (VIP). The somatostatin, GIP, CCK, and glucagon cells were increased in number in coeliac disease. The number of motilin cells was slightly increased, while secretin cells were reduced. Cells storing gastrin-17, substance P, or neurotensin were rare in all patients regardless of diagnosis. No PP immunoreactive cells were found and VIP was localised to neurons only. In biopsies from patients having a mucosa with ridging of villi the number of the various endocrine cell types did not differ from that in the control group.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 385455      PMCID: PMC1412522          DOI: 10.1136/gut.20.7.547

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Is GIP a glucagon cell constituent?

Authors:  J Alumets; R Håkanson; T O'Dorisio; K Sjölund; F Sundler
Journal:  Histochemistry       Date:  1978-12-13

2.  A reliable method for generating antibodies against pancreozymin, secretin and gastrin.

Authors:  W Schlegel; S Raptis
Journal:  Clin Chim Acta       Date:  1976-12       Impact factor: 3.786

3.  Enterochromaffin cells in the duodenal mucosa of children with coeliac disease.

Authors:  D N Challacombe; K Robertson
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

4.  Gallbladder inertia and sluggish enterohepatic circulation of bile-salts in coeliac disease.

Authors:  T S Low-Beer; K W Heaton; S T Heaton; A E Read
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

5.  Gut-hormone profile in coeliac disease.

Authors:  H S Besterman; S R Bloom; D L Sarson; A M Blackburn; D I Johnston; H R Patel; J S Stewart; R Modigliani; S Guerin; C N Mallinson
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

6.  Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.

Authors:  J Fahrenkrug; O V Schaffalitzky de Muckadell
Journal:  J Lab Clin Med       Date:  1977-06

7.  Increased tissue concentrations of 5-hydroxytryptamine in the duodenal mucosa of patients with coeliac disease.

Authors:  D N Challacombe; P D Dawkins; P Baker
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

8.  Secretin cells in coeliac disease.

Authors:  J M Polak; A G Pearse; S Van Noorden; S R Bloom; M A Rossiter
Journal:  Gut       Date:  1973-11       Impact factor: 23.059

9.  Radioimmunoassay for neurotensin, a hypothalamic peptide.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

10.  Heptadecapeptide gastrin: measurement in blood by specific radioimmunoassay.

Authors:  G J Dockray; I L Taylor
Journal:  Gastroenterology       Date:  1976-12       Impact factor: 22.682

View more
  23 in total

Review 1.  Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.

Authors:  Helen H Wang; Min Liu; Xiaodan Li; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2017-03-08       Impact factor: 4.686

2.  Histopathology, hormone products, and clinicopathological profile of endocrine tumors of the upper small intestine: A study of 44 cases.

Authors:  Carlo Capella; Cristina Riva; Guido Rindi; Fausto Sessa; Luciana Usellini; Annamaria Chiaravalli; Luciano Carnevali; Enrico Solcia
Journal:  Endocr Pathol       Date:  1991-06       Impact factor: 3.943

3.  Basal and fat-stimulated plasma peptide YY levels in celiac disease.

Authors:  P J Wahab; W P Hopman; J B Jansen
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

Review 4.  Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

5.  Human intestinal mucosal mast cells: evaluation of fixation and staining techniques.

Authors:  S Strobel; H R Miller; A Ferguson
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

6.  Plasma secretin concentrations and gastric pH in healthy subjects and patients with digestive diseases.

Authors:  J M Rominger; W Y Chey; T M Chang
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

7.  Gut endocrine cell population in coeliac disease estimated by immunocytochemistry using a monoclonal antibody to chromogranin.

Authors:  R Pietroletti; A E Bishop; F Carlei; M Bonamico; R V Lloyd; B S Wilson; A Ceccamea; E Lezoche; V Speranza; J M Polak
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

8.  Gastrointestinal regulatory peptide storage granule abnormalities in jejunal mucosal diseases.

Authors:  J Dawson; M G Bryant; S R Bloom; T J Peters
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

9.  Effect of predigested fat on intestinal stimulation of plasma cholecystokinin and gall bladder motility in coeliac disease.

Authors:  W P Hopman; G Rosenbusch; M P Hectors; J B Jansen
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 10.  Clinical aspects of GIP secretion.

Authors:  B Beck; C Villaume; G Debry
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.